For the third year in a row, Wynnewood’s Lankenau Medical Center has been named one of America’s 50 best hospitals by Healthgrades, writes John George for Philadelphia Business Journal.

The phase 2a LEGION-100 trial seeks to evaluate the safety and effectiveness of the SYNC-T/SV-102 combination therapy for treating metastatic castration-resistant prostate cancer (mCRPC) and to ...

Dr. Stephen E. Lankenau is a sociologist who combines public health concerns and mixed methods to the study of substance use and health outcomes associated with use, including homelessness, HIV/AIDS, ...

Dr. Lankenau is a sociologist who combines public health concerns and ethnographic methods to the study of substance use and health outcomes associated with use, including homelessness, HIV/AIDS, and ...